|
Rapid Sequence Induction and Intubation
|
E05.497.578.737 |
|
|
MDS1 and EVI1 Complex Locus Protein
|
D12.776.930.419 |
|
|
Anesthetics, Local
|
D27.505.954.427.210.100.200 |
|
|
Anesthetics
|
D27.505.954.427.210.100 |
|
|
Biopsy, Needle
|
E01.370.225.998.054.119 |
|
|
Interferon Regulatory Factor-2
|
D12.776.476.024.385.249 |
|
|
Otitis Media, Suppurative
|
C01.830.694 |
|
|
Suppuration
|
C01.830 |
|
|
Floxuridine
|
D13.570.230.430.432 |
|
|
Spinal Fractures
|
C26.404.812 |
|
|
Wasting Disease, Chronic
|
C10.574.843.925 |
|
|
Galactosephosphates
|
D09.894.417.370 |
|
|
Transfusion Reaction
|
D065227 |
[Complications of BLOOD TRANSFUSION. Included adverse reactions are common allergic and febrile reactions; hemolytic (delayed and acute) reactions; and other non-hemolytic adverse reactions such as infections and adverse immune reactions related to immunocompatibility.
, Transfusion reaction complications such as delayed suppression of ERYTHROPOIESIS may occur after destruction of autologous RED BLOOD CELLS in Hemolytic Transfusion Reaction.
] |
|
Non-Randomized Controlled Trials as Topic
|
D065228 |
[Works about a study where participants are assigned to a treatment, procedure, or intervention by methods that are not random. Non-randomized clinical trials are sometimes referred to as quasi-experimental clinical trials or non-equivalent control group designs.
] |
|
Dopamine and cAMP-Regulated Phosphoprotein 32
|
D12.776.631.249 |
|
|
Distal Myopathies
|
C05.651.534.500.074 |
|
|
MEDLINE
|
L01.313.500.750.300.710.500 |
|
|
MEDLARS
|
L01.313.500.750.300.710 |
|
|
Nephritis, Hereditary
|
C12.777.419.570.620 |
|
|
Public Expenditures
|
N03.219.840 |
|
